Andrew J. Pollard

2 ta ish

University of Oxford

1. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

   Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.554494

2. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

   Olivier J. Wouters, Kenneth C. Shadlen, Maximilian Salcher‐Konrad +4

   Sharh maqola20212 iqtibos

   ABIABI:AkademIndex/2026.other.554500